+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ivermectin"

COVID-19 Current Therapy Global Market Report 2024 - Product Thumbnail Image

COVID-19 Current Therapy Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Onchocerciasis - Pipeline Insight, 2024 - Product Thumbnail Image

Onchocerciasis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Coronavirus (COVID-19) Current Therapy Global Market Report 2023 - Product Thumbnail Image

Coronavirus (COVID-19) Current Therapy Global Market Report 2023

  • Report
  • February 2023
  • 250 Pages
  • Global
From
From
Pregnancy and Anti-Infective Agents - Product Thumbnail Image

Pregnancy and Anti-Infective Agents

  • Book
  • November 2020
From
Plumb's Veterinary Drug Handbook. Edition No. 10 - Product Thumbnail Image

Plumb's Veterinary Drug Handbook. Edition No. 10

  • Book
  • July 2023
  • 1568 Pages
  • 9 Results (Page 1 of 1)
Loading Indicator

Ivermectin is an anti-parasitic drug used to treat a variety of infectious diseases, including river blindness, scabies, and strongyloidiasis. It is a broad-spectrum antiparasitic drug, meaning it is effective against a wide range of parasites. Ivermectin is also used to treat head lice and is available in both topical and oral forms. It is generally well-tolerated and has few side effects. Ivermectin is a widely used drug in the treatment of infectious diseases, and its market is growing. It is used in both human and veterinary medicine, and is increasingly being used in the treatment of neglected tropical diseases. Ivermectin is also being studied for its potential use in the treatment of other diseases, such as cancer and HIV. Some companies in the Ivermectin market include Merck & Co., Inc., Pfizer, Inc., Sanofi, Bayer AG, and Novartis AG. Show Less Read more